Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKYA | AZN | AMGN | GILD | BMY |
| Company | Akoya Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.4100 | 168.46 | 367.95 | 134.28 | 60.76 |
| High | 1.6400 | 168.65 | 370.29 | 135.50 | 61.35 |
| Low | 1.2900 | 164.06 | 363.65 | 132.91 | 60.03 |
| Latest | 1.2900 | 164.52 | 364.17 | 133.21 | 60.16 |
| Change | -0.0700 | -4.38 | -2.12 | -1.07 | -0.58 |
| % Change | -5.15% | -2.59% | -0.58% | -0.80% | -0.95% |
| Volume | 715,200 | 2,552,900 | 1,922,100 | 4,103,900 | 10,183,900 |
| 20-Day Average Volume | 496,515 | 2,707,425 | 2,272,850 | 7,706,660 | 12,493,186 |
| Previous Close | 1.3600 | 168.90 | 366.29 | 134.28 | 60.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2755 | 180.09 | 360.90 | 130.01 | 57.65 |
| 20-Day Raw Stochastic | 36.36% | 1.42% | 64.90% | 57.98% | 74.32% |
| 20-Day Relative Strength | 51.22 | 38.19 | 55.66 | 53.29 | 56.64 |
| Weighted Alpha | -51.02 | +1.56 | +19.44 | +12.32 | +25.04 |
| Today's Opinion | 40% Sell | 88% Sell | 72% Buy | 8% Sell | 56% Buy |
| Previous Opinion | 40% Sell | 88% Sell | 72% Buy | 8% Sell | 56% Buy |
| Last Month's Opinion | 80% Sell | 56% Sell | 24% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.03% since 06/27/25 | -2.92% since 07/13/26 | +1.03% since 07/13/26 | +1.38% since 07/13/26 | +1.38% since 07/13/26 |
| Low | 1.2600 on 06/30/25 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 129.40 on 07/15/26 | 56.78 on 07/14/26 |
| High | 1.6400 on 07/07/25 | 170.37 on 07/16/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | +11.21% since 06/06/25 | -5.95% since 06/18/26 | +7.87% since 06/18/26 | +7.64% since 06/18/26 | +11.41% since 06/18/26 |
| Low | 1.0900 on 06/09/25 | 164.06 on 07/20/26 | 337.60 on 06/22/26 | 123.00 on 06/22/26 | 53.99 on 06/22/26 |
| High | 1.6400 on 07/07/25 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | +10.26% since 04/07/25 | -18.02% since 04/20/26 | +4.00% since 04/20/26 | -1.96% since 04/20/26 | +1.74% since 04/20/26 |
| Low | 0.9310 on 05/15/25 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.6400 on 07/07/25 | 198.99 on 04/21/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | -50.76% since 01/07/25 | -8.54% since 01/20/26 | +10.02% since 01/20/26 | +7.31% since 01/20/26 | +10.96% since 01/20/26 |
| Low | 0.9310 on 05/15/25 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 3.4200 on 01/10/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 64,441 | 261,948,336 | 197,689,664 | 166,718,016 | 124,035,400 |
| Shares Outstanding, K | 49,954 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 81,670,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -55,370,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 16,640,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -15,650,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.36 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 05/12/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/04/25 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.28 | 16.81 | 16.28 | 10.20 |